Karen Snyder
About Karen Snyder
Karen Snyder is the Associate Director, Translational Medicine Planning & Execution Lead at Bristol Myers Squibb, with extensive experience in the biotechnology and pharmaceutical industries.
Current Role at Bristol Myers Squibb
Karen Snyder currently serves as the Associate Director and Translational Medicine Planning & Execution Lead at Bristol Myers Squibb. In her role, she is responsible for managing translational activities that support biomarkers within clinical trials. She operates from a remote location and applies her extensive experience to ensure the effective execution of translational medicine projects.
Previous Experience at Amgen
Karen Snyder has an extensive history with Amgen, where she held multiple positions. From 2019 to 2021, she worked as a Clinical Biomarkers and Diagnostics professional in a remote capacity. Prior to that, she was responsible for Research Operations Management in Comparative Biology and Safety Sciences, operating in the San Francisco Bay Area from 2017 to 2019 and Thousand Oaks, CA from 2012 to 2017. Her tenure at Amgen emphasized her expertise in research operations and biomarkers.
Early Career at Merck
Karen Snyder's career at Merck spanned various roles from 2000 to 2012. She started as a Staff Biochemist and gradually moved up to Research Biochemist, then Senior Research Biochemist. She also served as an Outsourcing Manager/Technical Supervisor and later as an Associate Manager. Her responsibilities included biochemical research and managerial duties related to technical and outsourcing projects. She primarily worked in Rahway, NJ, and demonstrated a robust background in biochemistry and research management.
Educational Background
Karen Snyder holds a Master of Science degree in Molecular Biology from Georgian Court University, where she studied from 1999 to 2003. She also earned a Bachelor of Science in Chemistry/Medical Technology from Elizabethtown College, completed between 1991 and 1995. Additionally, she attained ASCP and NCA certifications in Medical Technology from Monmouth Medical Center's School of Medical Technology, where she studied from 1994 to 1995.
Specializations and Expertise
Karen Snyder specializes in Oncology Tumor Microenvironment (TME) research and has a strong background in Good Laboratory Practice (GLP) and Human Tissue Science. She has a demonstrated history of working in both the biotechnology and pharmaceutical industries, particularly excelling in managing translational activities to support biomarkers within clinical trials. Her involvement in the delivery of translational activities spans multiple assets, showcasing her comprehensive understanding and application of scientific and operational expertise.